Evidence-Based Medicine Guidelines
Intravenous secretin for autism spectrum disorders
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Secretin for Autism Spectrum Disorders." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456424/all/Intravenous_secretin_for_autism_spectrum_disorders.
Intravenous secretin for autism spectrum disorders. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456424/all/Intravenous_secretin_for_autism_spectrum_disorders. Accessed June 7, 2023.
Intravenous secretin for autism spectrum disorders. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456424/all/Intravenous_secretin_for_autism_spectrum_disorders
Intravenous Secretin for Autism Spectrum Disorders [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 June 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456424/all/Intravenous_secretin_for_autism_spectrum_disorders.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous secretin for autism spectrum disorders
ID - 456424
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456424/all/Intravenous_secretin_for_autism_spectrum_disorders
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
